Few would argue the United States, or any country for that matter, was prepared for the COVID-19 pandemic, even though, starting in 2003, the U.S. devoted $5.6 billion to fund Project Bioshield, running through 2013, and another $2.8 billion of funding through 2018. Project Bioshield was designed to prepare the United States against a bio attack, including provisions for the stockpiling and distribution of vaccines.
Though Covid-19 was a new virus, congressional testimony from 2003 paints a concerning picture about what we knew – and when – about the family of viruses from which it originated.
Read Full Article »